New Delhi, Dec. 16 -- Anupam Mittal, an angel investor and a judge on Shark Tank India, has weighed in on the recent launch of Ozempic in India, rendering a wider perspective on the drug's popularity through a LinkedIn post. Mittal asserted that while Indians have long aspired to be fit, many are now opting for easier solutions rather than sustained lifestyle changes. "Maybe that's why Ozempic feels like a gold injection right now," he said.

Ozempic has been widely discussed internationally for its use among celebrities and its impact on weight loss; however, the global diabetes drug's managing director has underlined that its India rollout is focused on diabetes care, evidence-based medicine, and responsible prescription practices.

The...